References
Booth, B., and R. Zemmel. 2004. Prospects for productivity. Nature Reviews Drug Discovery 3(5): 451-456.
Brinkman, W. F., D. E. Haggan, and W. W. Troutman. 1997. A history of the invention of the transistor and where it will lead us. IEEE Journal of Solid-State Circuits 32(12): 1858-1865.
CBO (Congressional Budget Office). 1990. Using R&D Consortia for Commercial Innovation: SEMATECH, X-Ray Lithography and High-Resolution Systems. July. Pp. 37-38. http://www.cbo.gov/ftpdocs/77xx/doc7771/90-CBO-038.pdf (accessed October 7, 2010).
CBO. 2009. Pharmaceutical R&D and the Evolving Market for Prescription Drugs. Economic and Budget Issue Brief. October 26. http://www.cbo.gov/ftpdocs/106xx/doc10681/DrugR&D.shtml (accessed October 7, 2010).
Daly, A. K., P. T. Donaldson, P. Bhatnagar, Y. Shen, I. Pe’er, A. Floratos, M. J. Daly, D. B. Goldstein, S. John, M. R. Nelson, J. Graham, B. K. Park, J. F. Dillon, W. Bernal, H. J. Cordell, M. Pirmohamed, G. P. Aithal, C. P. Day; DILIGEN Study; International SAE Consortium. 2009. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nature Genetics 41(7):816-819.
Eiseman, E., and S. B. Haga. 1999. Handbook of Human Tissue Sources: A National Resource of Human Tissue Samples. Santa Monica, CA: RAND.
Ge, D., J. Fellay, A. J. Thompson, J. S. Simon, K. V. Shianna, T. J. Urban, E. L. Heinzen, P. Qiu, A. H. Bertelsen, A. J. Muir, M. Sulkowski, J. G. McHutchison, and D. B. Goldstein. 2009. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461(7262):399-401.
Harmon, A. 2008. Taking a peek at the experts’ genetic secrets. New York Times, October 19.
Hughes, B. 2010. 2009 FDA drug approvals. Nature Reviews Drug Discovery 9(2):89-92.
IOM (Institute of Medicine). 2010. Workshop: Extending the Spectrum of Precompetitive Collaboration in Oncology Research. February 9 and 10. http://www.iom.edu/Activities/Disease/NCPF/2010-FEB-09.aspx (accessed October 7, 2010).
NCI (National Cancer Institute). 2007. National Cancer Institute Best Practices for Biospecimen Resources. Bethesda, MD.
Paul, S. M., D. S. Mytelka, C. T. Dunwiddie, C. C. Persinger, B. H. Munos, S. R. Lindborg, and A. L. Schacht. 2010. How to improve R&D productivity: The pharmaceutical industry’s grand challenge. Nature Reviews Drug Discovery 9(3):203-214.
Sakakibara, K. 1993. R&D cooperation among competitors: A case study of the VLSI semiconductor research project in Japan. Journal of Engineering and Technology Management 10(4):393-407.
Spruessel, A., G. Steimann, M. Jung, S. A. Lee, T. Carr, A. Fentz, J. Spangenberg, C. Zornig, H. H. Juhl, and K. A. David. 2004. Tissue ischemia time affects gene and protein expression patterns within minutes following surgical tumor excision. BioTechniques 36:1030-1037.
Sreekumar, A., L. M. Poisson, T. M. Rajendiran, A. P. Khan, Q. Cao, J. Yu, B. Laxman, R. Mehra, R. J. Lonigro, Y. Li, M. K. Nyati, A. Ahsan, S. Kalyana-Sundaram, B. Han, X. Cao, J. Byun, G. S. Omenn, D. Ghosh, S. Pennathur, D. C. Alexander, A. Berger, J. R. Shuster, J. T. Wei, S. Varambally, C. Beecher, and A. M. Chinnaiyan. 2009. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457(7231):910-914.
Thomas, D. L., C. L. Thio, M. P. Martin, Y. Qi, D. Ge, C. O’Huigin, J. Kidd, K. Kidd, S. I. Khakoo, G. Alexander, J. J. Goedert, G. D. Kirk, S. M. Donfield, H. R. Rosen, L. H. Tobler, M. P. Busch, J. G. McHutchison, D. B. Goldstein, and M. Carrington. 2009. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461(7265):798-801.
Voight, B. F., L. J. Scott, V. Steinthorsdottir, A. P. Morris, C. Dina, R. P. Welch, E. Zeggini, C. Huth, Y. S. Aulchenko, G. Thorleifsson, L. J. McCulloch, T. Ferreira, H. Grallert, N. Amin, G. Wu, C. J. Willer, S. Raychaudhuri, S. A. McCarroll, C. Langenberg, O. M. Hofmann, J. Dupuis, L. Qi, A. V. Segre, M. van Hoek, P. Navarro, K. Ardlie, B. Balkau, R. Benediktsson, A. J. Bennett, R. Blagieva, E. Boerwinkle, L. L. Bonnycastle, K. B. Bostrom, B. Bravenboer, S. Bumpstead, N. P. Burtt, G. Charpentier, G. P. S. Chines, M. Cornelis, D. J. Couper, G. Crawford, A. S. F. Doney, K. S. Elliott, A. L. Elliott, M. R. Erdos, C. S. Fox, C. S. Franklin, M. Ganser, C. Gieger, N. Grarup, T. Green, S. Griffin, C. J. Groves, C. Guiducci, S. Hadjadj, N. Hassanali, C. Herder, B. Isomaa, A. U. Jackson, P. R. V. Johnson, T. Jorgensen, W. H. L. Kao, N. Klopp, A. Kong, P. Kraft, J. Kuusisto, T. Lauritzen, M. Li, A. Lieverse, C. M. Lindgren, V. Lyssenko, M. Marre, T. Meitinger, K. Midthjell, M. A. Morken, N. Narisu, P. Nilsson, K. R. Owen, F. Payne, J. R. B. Perry, A.-K. Petersen, C. Platou, C. Proenca, I. Prokopenko, W. Rathmann, N. W. Rayner, N. R. Robertson, G. Rocheleau, M. Roden, M. J. Sampson, R. Saxena, B. M. Shields, P. Shrader, G. Sigurdsson, T. Sparso, K. Strassburger, H. M. Stringham, Q. Sun, A. J. Swift, B. Thorand, J. Tichet, T. Tuomi, R. M. van Dam, T. W. van Haeften, T. van Herpt, J. V. van Vliet-Ostaptchouk, G. B. Walters, M. N. Weedon, C. Wijmenga, J. Witteman, R. N. Bergman, S. Cauchi, F. S. Collins, A. L. Gloyn, U. Gyllensten, T. Hansen, W. A. Hide, G. A. Hitman, A. Hofman, D. J. Hunter, K. Hveem, M. Laakso, K. L. Mohlke, A. D. Morris, C. N. A. Palmer, P. P. Pramstaller, I. Rudan, E. Sijbrands, L. D. Stein, J. Tuomilehto, A. Uitterlinden, M. Walker, N. J. Wareham, R. M. Watanabe, G. R. Abecasis, B. O. Boehm, H. Campbell, M. J. Daly, A. T. Hattersley, F. B. Hu, J. B. Meigs, J. S Pankow, H. E. Pedersen, O. Wichmann, I. Barroso, J. C. Florez, T. M. Frayling, L. Groop, R. Sladek, U. Thorsteinsdottir, J. F. Wilson, T. Illig, P. Froguel, C. M. van Duijn, K. Stefansson, D. Altshuler, M. Boehnke, and M. I. McCarthy. 2010. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nature Genetics 42(7):579-589.
Willett, W. C., W. J. Blot, G. A. Colditz, A. R. Folsom, B. E. Henderson, and M. J. Stampfer. 2007. Merging and emerging cohorts. Nature 445:257-258.
Yuille, M., K. Dixon, A. Platt, S. Pullum, D. Lewis, A. Hall, and W. Ollier. 2010. The UK DNA banking network: A “fair access” biobank. Cell Tissue Bank 11(3):241-251.
